World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
55
Citations
10428
World Ranking
3833
National Ranking
1500

Overview

John P. DeVincenzo is affiliated with Middle Tennessee State University in the United States. Their research primarily revolves around the field of Medicine, with a focus on epidemiology, infectious diseases, pulmonary and respiratory medicine, pediatrics, perinatology, child health, and surgery.

The scientist's main research topics include:

  • Respiratory viral infections research
  • Neonatal respiratory health research
  • Congenital diaphragmatic hernia studies
  • Pneumonia and respiratory infections
  • Viral gastroenteritis research and epidemiology
  • Neonatal and fetal brain pathology
  • Fetal and pediatric neurological disorders

They have contributed to multiple peer-reviewed papers. Some of their recent publications include:

  • "Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants," 2020, New England Journal of Medicine
  • "Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study," 2021, The Journal of Infectious Diseases
  • "Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine," 2023, Science Translational Medicine
  • "Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity," 2020, BMC Microbiology
  • "Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study," 2020, The Journal of Infectious Diseases

Frequent co-authors collaborating with John P. DeVincenzo include:

  • Stephania A. Cormier
  • Mahdieh Shabanian
  • David Siefker
  • Luan D. Vu
  • Dahui You

The scientist has published multiple times in key venues such as:

  • The Journal of Infectious Diseases
  • arXiv (Cornell University)
  • The Journal of Immunology
  • Influenza and Other Respiratory Viruses
  • Research Square (Research Square)

Best Publications

  • Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.

    M. Pamela Griffin;Yuan Yuan;Therese Takas;Joseph B. Domachowske

  • A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

    John DeVincenzo;Robert Lambkin-Williams;Tom Wilkinson;Jeffrey Cehelsky

  • Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

    Vasanthi Avadhanula;Carina A. Rodriguez;John P. DeVincenzo;Yan Wang

  • Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus

    John P. DeVincenzo;Tom Wilkinson;Akshay Vaishnaw;Jeff Cehelsky

  • Oral GS-5806 activity in a respiratory syncytial virus challenge study

    John P DeVincenzo;Richard J Whitley;Richard L Mackman;Cecilia Scaglioni-Weinlich

  • Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)

    John DeVincenzo;Jeffrey E Cehelsky;Rene Alvarez;Sayda Elbashir

  • Respiratory syncytial virus load predicts disease severity in previously healthy infants.

    John P DeVincenzo;Chadi M El Saleeby;Chadi M El Saleeby;Andrew J Bush

  • Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children

    Chadi M. El Saleeby;Andy J. Bush;Lisa M. Harrison;Jody A. Aitken

  • Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.

    Maximillian S. Habibi;Agnieszka Jozwik;Spyridon Makris;Jake Dunning

  • Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein

    Richard Malley;John DeVincenzo;Octavio Ramilo;Penelope H. Dennehy

  • Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

    John P DeVincenzo;Matthew W McClure;Julian A Symons;Hosnieh Fathi

  • RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

    Martin R Zamora;Marie Budev;Mark Rolfe;Jens Gottlieb

  • SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

    E Kaitlynn Allen;Adrienne G Randolph;Tushar Bhangale;Pranay Dogra

  • Mucosal Immune Responses Predict Clinical Outcomes during Influenza Infection Independently of Age and Viral Load

    Christine M. Oshansky;Andrew J. Gartland;Sook-San Wong;Trushar Jeevan

  • Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants

    Steven C. Buckingham;Andrew J. Bush;John P. Devincenzo

  • RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

    Rene Alvarez;Sayda Elbashir;Todd Borland;Ivanka Toudjarska

  • Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33.

    Jordy Saravia;Dahui You;Dahui You;Bishwas Shrestha;Bishwas Shrestha;Sridhar Jaligama;Sridhar Jaligama

  • ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients.

    Unknown

  • Comparison of a Real-Time Reverse Transcriptase PCR Assay and a Culture Technique for Quantitative Assessment of Viral Load in Children Naturally Infected with Respiratory Syncytial Virus

    Stephanie M. Perkins;David L. Webb;Shauna A. Torrance;Chadi El Saleeby;Chadi El Saleeby

  • Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age

    Chadi M. El Saleeby;Grant W. Somes;John P. DeVincenzo;Aditya H. Gaur

  • A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection : effects on RSV quantity and clinical outcome

    Steven C. Buckingham;Hasan S. Jafri;Andrew J. Bush;Cecilia M. Carubelli

Frequent Co-Authors

Octavio Ramilo
Octavio Ramilo St. Jude Children's Research Hospital
Paul G. Thomas
Paul G. Thomas St. Jude Children's Research Hospital
Yonatan H. Grad
Yonatan H. Grad Harvard University
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Eric A. F. Simões
Eric A. F. Simões University of Colorado Denver
Richard J. Webby
Richard J. Webby St. Jude Children's Research Hospital
Joseph B. Domachowske
Joseph B. Domachowske SUNY Upstate Medical University
Richard Malley
Richard Malley Boston Children's Hospital
Edward E. Walsh
Edward E. Walsh University of Rochester Medical Center
William C. Gruber
William C. Gruber Pfizer (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Many programs focus on healthcare and biological sciences, fields that often welcome graduates with a background in microbiology.

Those with unique challenges, such as a criminal record, may find guidance in options highlighted by college degrees for felons, showing how to pursue education and careers despite past setbacks.

Another relevant path is becoming a functional medicine NP, blending specialized medical knowledge with patient-centered care, which can complement a microbiology foundation.

For those interested in healthcare administration, obtaining certifications like a CPC credential helps advance careers in medical coding, an essential aspect of managing health information.

Similarly, a career in health information management offers promising opportunities, with insights available about health information management salary entry-level and potential growth.

Exploring these online degrees and career pathways can provide microbiology students with versatile options beyond the lab, addressing demand in healthcare, data management, and patient care sectors.

Best Scientists Citing John P. DeVincenzo

Trending Scientists

Recently Published Articles